Sarcoma

Program Leadership

Brian Brigman, MD, PhD
Director
Richard F. Riedel, MD
Assoc. Director, Clinical Research
David Kirsch, MD, PhD
Assoc. Director, Basic Research

Program Overview

The Duke Sarcoma Research Program uses a multidisciplinary, patient-centric approach to diagnose and treat bone and soft-tissue sarcomas. Through unsurpassed clinical care, personalized treatment planning and delivery, and state-of-the-art basic scientific and clinical research, the program is the center of excellence for the treatment of sarcoma in the Southeast.

The leaders of the program have created a robust basic, translational and clinical research portfolio. They want to have a clinical trial option for every patient.

Researchers in this program have conducted and are conducting several sarcoma-specific clinical trials, including pharmaceutically-sponsored, investigator-initiated and cooperative group trials. Their basic science research centers on mouse models of soft tissue sarcoma and rhabdomyosarcoma developed by members of the Duke Sarcoma Research Program.

Strengths of the program include:

  • multidisciplinary clinic
  • prospective multidisciplinary database
  • monthly multidisciplinary research conferences
  • weekly multidisciplinary clinical case conferences
  • internationally recognized sarcoma research program
  • an annual run/walk event (Strike Out For Sarcoma) to raise research support for the program

Additional Contacts

Natalie Wilde, Administrative Director
Phone: 919.613.1920

Stephanie McFadden, New Patient Coordinator
Phone: 919.613.5550

Toya Hobbs, Assistant Research Practice Manager
Phone: 919.684.2310

Make An Appointment

To make an appointment, please call 888.275.3853. For more information on sarcoma cancer care at Duke Health, visit Sarcoma or call 1-877-SARC-DUK(E). To find a doctor, visit Find A Specialist.